Short interfering RNA (siRNA) analogues
The present invention is directed to novel double-stranded short interfering (siRNA) analogs comprising locked nucleic acid (LNA) monomers. Such compounds induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). The compounds disclosed herein has improved properties compared to non-modified siRNAs and may, accordingly, be useful as therapeutic agents, e.g., in the treatment of various cancer forms. More particularly, the present invention is directed to siRNA analogs comprising a sense strand and an antisense strand, wherein each strand comprises 12-35 nucleotides and wherein the siRNA analogs comprise at least one locked nucleic acid (LNA) monomer.
1. A double-stranded compound comprising a sense strand and an antisense strand, wherein each strand comprises 17-25 nucleotides, wherein at least one of the strands has a 3′ overhang and wherein said compound comprises at least one locked nucleic acid (LNA) monomer located at the 5′ end of the sense strand, and wherein no LNA monomer is located at the 5′ end of the antisense strand.
2. The compound according to claim 1 , wherein the sense strand comprises 1-10 LNA monomers.
3. The compound according to claim 1 , wherein at two LNA monomers are located at the 5′ end of the sense strand.
4. The compound according to claim 1 , wherein at least two LNA monomers are located at the 5′ end of the sense strand.
5. The compound according to claim 1 , wherein at least one LNA monomer is located at the 3′ end of the sense strand.
6. The compound according to claim 1 , wherein at least two LNA monomers are located at the 3′ end of the sense strand.
7. The compound according to claim 1 , wherein the antisense strand comprises 1-10 LNA monomers.
8. The compound according to claim 1 , wherein at least one LNA monomer is located at the 3′ end of the antisense strand.
9. The compound according to claim 1 , wherein at least two LNA monomers are located at the 3′ end of the antisense strand.
10. The compound according to claim 1 , wherein at least three LNA monomers are located at the 3′ end of the antisense strand.
11. The compound according to claim 1 , wherein the sense strand comprises at least one LNA and the antisense strand comprises at least one LNA monomer.
12. The compound according to claim 1 , wherein the sense strand comprises 1-10 LNA monomers and the antisense strand comprises 1-10 LNA monomers.
13. The compound according to claim 1 , wherein the sense strand comprises at least one LNA monomer at the 5′ end and at least one LNA monomer at the 3′ end, and wherein the antisense strand comprises at least one LNA monomer at the 3′ end.
14. The compound according to claim 1 , wherein the sense strand comprises at least one LNA monomer at the 5′ end and at least one LNA monomer at the 3′ end, and wherein the antisense strand comprises at least two LNA monomers at the 3′ end.
15. The compound according to claim 1 , wherein the sense strand comprises at least two LNA monomers at the 5′ end and at least two LNA monomers at the 3′ end, and wherein the antisense strand comprises at least two LNA monomers at the 3′ end.
16. The compound according to claim 1 , wherein the sense strand comprises at least two LNA monomers at the 5′ end and at least two LNA monomers at the 3′ end, and wherein the antisense strand comprises at least three LNA monomers at the 3′ end.
17. The compound according to claim 1 , wherein the sense strand comprises at least one LNA monomer in at least one of the positions 9-13 counted from the 5′ end.
18. The compound according to claim 1 , wherein the sense strand comprises a LNA monomer in position 10.
19. The compound according to claim 1 , wherein the sense strand comprises a LNA monomer in position 11.
20. The compound according to claim 1 , wherein the sense strand comprises a LNA monomer in position 12.
21. The compound according to claim 17 , wherein the sense strand comprises at least one LNA monomer at the 5′ end and at least one LNA monomer at the 3′ end, and wherein the antisense strand comprises at least one LNA monomer at the 3′ end.
22. The compound according to claim 17 , wherein the sense strand comprises at least one LNA monomer at the 5′ end and at least one LNA monomer at the 3′ end, and wherein the antisense strand comprises at least two LNA monomers at the 3′ end.
23. The compound according to claim 17 , wherein the sense strand comprises at least two LNA monomers at the 5′ end and at least two LNA monomers at the 3′ end, and wherein the antisense strand comprises at least two LNA monomers at the 3′ end.
24. The compound according to claim 17 , wherein the sense strand comprises at least two LNA monomers at the 5′ end and at least two LNA monomers at the 3′ end, and wherein the antisense strand comprises at least three LNA monomers at the 3′ end.
25. The compound according to claim 1 , wherein each strand comprises 20-22 nucleotides.
26. The compound according to claim 17 , wherein each strand comprises 20-22 nucleotides.
27. The compound according to claim 24 , wherein each strand comprises 20-22 nucleotides.